5:46 PM
 | 
Feb 21, 2014
 |  BC Extra  |  Company News

Ariad adds Denner to board

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) appointed Alex Denner a director for a two-year term. According to SEC filings, hedge fund Sarissa Capital Management -- which Denner founded in 2012 after he stepped down as managing director of...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >